• Rotigotine: Dopamine D2/D3 Receptor Agonist for Parkinson’s

  2026-05-25

  Rotigotine is a validated dopamine D2/D3 receptor agonist with robust antiparkinsonian activity. Its neuroprotective and antioxidant effects are reproducible in both cell-based and animal models. Rotigotine is a reference compound for dopaminergic pathway studies and translational research.

• Aclacinomycin A: Unraveling rDNA Damage, PML Dynamics, and A

  2026-05-25

  Explore how Aclacinomycin A (Aclarubicin) uniquely induces ribosomal DNA damage and PML-nucleolar associations, expanding its role beyond standard apoptosis assays. This in-depth article connects molecular mechanisms with the latest research, offering practical insight for innovative cancer biology workflows.

• Vincristine Sulfate in Cancer Research: Workflows & Solution

  2026-05-24

  Vincristine sulfate, a powerful microtubule disrupter, underpins robust experimental designs in cancer research with unrivaled clarity on protocol execution and troubleshooting. This article delivers stepwise workflows, advanced applications, and optimization strategies to ensure reproducibility and high-impact results.

• Bafilomycin C1: Applied Workflows for V-ATPase Inhibition Re

  2026-05-23

  Bafilomycin C1 empowers precise control of lysosomal acidification and autophagy inhibition, transforming high-content screening and disease modeling. This article provides actionable protocols, troubleshooting strategies, and insights for leveraging Bafilomycin C1 in advanced cell biology and drug discovery workflows.

• Astrocytic GAT-3 Modulates Synaptic Transmission in Dentate

  2026-05-22

  The reference study demonstrates that astrocytic GAT-3 regulates synaptic transmission and memory formation in the dentate gyrus via Ca2+-dependent signaling. These findings clarify glial involvement in hippocampal circuit plasticity and offer new mechanistic insights for cognitive research.

• HGFA Identified as a Serum Biomarker for Pulmonary Hypertens

  2026-05-22

  Zhang et al. employed proteomic profiling and Mendelian randomization to identify hepatocyte growth factor activator (HGFA) as a promising noninvasive biomarker for pulmonary arterial hypertension (PAH). Their multi-tiered approach supports the diagnostic relevance of HGFA and provides new insights into PAH pathobiology and translational modeling.

• Biotin Azide: Precision Bio-Orthogonal Labeling via Click Ch

  2026-05-21

  Biotin Azide (N-(3-azidopropyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide) is a biotinylation reagent enabling highly specific bio-orthogonal labeling of alkynylated biomolecules. Its copper-catalyzed azide-alkyne cycloaddition (CuAAC) compatibility ensures robust, mild, and selective conjugation for downstream affinity purification, detection, and mechanistic studies.

• Halazone: Mechanistic Nuances and Protocol Precision in Rese

  2026-05-21

  Explore Halazone, a leading antimicrobial sulfonamide derivative, through the lens of advanced mechanistic insights and protocol optimization. This article uniquely analyzes sodium channel modulation and disinfection performance, empowering research with evidence-backed, application-focused guidance.

• 3-Aminobenzamide (PARP-IN-1): Redefining PARP Inhibition in

  2026-05-20

  Explore how 3-Aminobenzamide (PARP-IN-1) enables advanced research into poly (ADP-ribose) polymerase inhibition, bridging oxidative stress, inflammatory signaling, and antiviral immunity. This article offers unique insights and protocol guidance for maximizing experimental impact.

• Bafilomycin C1: Elevating Translational Research in Disease

  2026-05-20

  This thought-leadership article explores the mechanistic depth and translational value of Bafilomycin C1 as a vacuolar H+-ATPases inhibitor, highlighting its pivotal role in autophagy assays, apoptosis research, and high-content phenotypic screening. Drawing on recent breakthroughs in iPSC-derived cell models and deep learning-driven toxicity detection, we provide strategic guidance for translational researchers seeking to de-risk drug discovery and optimize disease modeling workflows. Uniquely, this article bridges rigorous mechanistic insight with actionable recommendations, surpassing standard product pages by integrating evidence-based protocol advice, competitive context, and future outlook.

• Bestatin Enhances Endothelial Invasion in Fibrin: Novel Insi

  2026-05-19

  The reference study challenges conventional views by demonstrating that the aminopeptidase inhibitor bestatin, previously recognized for anti-angiogenic effects, actually stimulates microvascular endothelial cell invasion within a fibrin matrix. This finding highlights the complexity of matrix-specific responses in angiogenesis and underscores the need for targeted approaches in vascular research.

• 7ACC2 in Cancer Immunometabolism: Beyond MCT1 Inhibition

  2026-05-19

  Explore how 7ACC2, a potent monocarboxylate transporter 1 inhibitor, uniquely enables interrogation of lactate dynamics and immunometabolic checkpoints in cancer. This article integrates recent advances from immunology to provide actionable insight for advanced cancer metabolism research.

• T0070907: Precision PPARγ Antagonist for Advanced Cellular R

  2026-05-18

  T0070907 is a nanomolar PPARγ antagonist enabling precise modulation of PPARγ signaling pathways in adipogenesis, cancer biology, and inflammatory models. Its selectivity and robust performance streamline experimental reproducibility and troubleshooting for both routine and specialized assays.

• Suhuang Capsule Attenuates ER Stress and NLRP3 Activation in

  2026-05-18

  This study demonstrates that Suhuang antitussive capsule ameliorates pulmonary dysfunction in a rat model of cough variant asthma (CVA) by suppressing endoplasmic reticulum (ER) stress and downstream NLRP3 inflammasome activation. The findings clarify the mechanistic links between ER stress, mitochondrial dynamics, and inflammasome-mediated inflammation in CVA, providing a pharmacological rationale for targeting these pathways in respiratory disease.

• Anisomycin as a JNK Agonist: Applied Workflows & Troubleshoo

  2026-05-17

  Anisomycin is a potent and specific JNK agonist instrumental for dissecting apoptosis and cellular stress pathways. This guide details deployment strategies, protocol optimization, and troubleshooting for maximizing its impact in cancer cell and neurobiology research, drawing on evidence from both oncology and advanced memory maintenance studies.

15812 records 1/1055 page Next 12345 下5页 Last page